WeVote
Log In

Bill

Bill

A 2698

Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause

2025 Regular Session Introduced by Phara Souffrant Forrest and 2 co-sponsors

Bill A 2698 launches a public awareness campaign on hormone replacement therapy, empowering women in perimenopause and menopause to make informed health decisions.

SUBSTITUTED BY S1720
0
WeVote Research Nonpartisan
Bill Summary · A 2698

Summary of Bill A 2698

Bill Overview

  • Bill Number: A 2698
  • Title: Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause
  • Status: Substituted by S 1720
  • Introduced: January 22, 2025
  • Classification: Bill

Purpose and Intent

The primary aim of Bill A 2698 is to establish a public awareness campaign focused on hormone replacement therapy (HRT) as a treatment option for women experiencing symptoms related to perimenopause and menopause. The bill seeks to educate the public about the benefits and risks associated with HRT, thereby empowering women to make informed decisions regarding their health during this transitional phase.

Key Provisions

While the specific provisions of Bill A 2698 are not detailed in the provided information, the following key elements can be inferred based on its purpose:
- Awareness Campaign: The bill proposes the creation of a structured campaign that may include informational materials, workshops, and outreach programs aimed at educating women about HRT.
- Focus on Symptoms: The campaign will likely address common symptoms of perimenopause and menopause, such as hot flashes, mood swings, and sleep disturbances, and how HRT can alleviate these symptoms.
- Health Education: The initiative may also include partnerships with healthcare providers to ensure accurate information is disseminated and to encourage discussions between patients and doctors regarding treatment options.

Affected Parties

The bill primarily affects:
- Women in Perimenopause and Menopause: The campaign is designed to directly benefit women experiencing these life stages by providing them with essential information about HRT.
- Healthcare Providers: Doctors and healthcare professionals may be involved in the campaign, enhancing their ability to discuss HRT with patients.
- Public Health Organizations: These organizations may play a role in implementing the awareness campaign and distributing educational materials.

Legislative Timeline

  • January 22, 2025: Bill A 2698 was introduced and referred to the Health Committee.
  • May 19, 2025: The bill was reported and referred to the Ways and Means Committee.
  • May 27, 2025: The bill was reported and referred to the Rules Committee.
  • June 4, 2025: The bill was reported, ordered to third reading, and subsequently substituted by S 1720.

Related Bills

  • S 1720: This is the companion bill to A 2698, which has taken precedence in the legislative process. Further details on S 1720 would provide insights into any additional provisions or changes made to the original intent of A 2698.

Conclusion

Bill A 2698 represents a significant step towards enhancing awareness and understanding of hormone replacement therapy among women facing perimenopause and menopause. By establishing a dedicated campaign, the bill aims to improve health outcomes and empower women with knowledge about their treatment options. The substitution by S 1720 indicates a continued legislative effort to address this important health issue.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.